GIA-632
N/A
Report date: 2026/05/15 20:01:45
Base Information
Drug NameGIA-632
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[12]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNovartis Ag
China Registration ClassN/A
Develop Information
Active CompaniesNovartis Pharma AgNovartis Pharma Stein AgChina Novartis Institutes For Biomedical Research Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A